Role of Coumadin in Preventing Thromboembolism in Atrial Fibrillation (AF) Patients Undergoing Catheter Ablation
Status:
Completed
Trial end date:
2014-04-01
Target enrollment:
Participant gender:
Summary
This study aims to explore the risk of periprocedural thromboembolic events in continuous
versus interrupted Coumadin therapy in a large, randomized high-risk patient population
undergoing radio-frequency catheter ablation for atrial fibrillation.
Phase:
Phase 3
Details
Lead Sponsor:
Texas Cardiac Arrhythmia Research Foundation
Collaborators:
California Pacific Medical Center Case Western Reserve University Catholic University, Italy Southlake Regional Health Centre Stanford University University of Kansas